Stay updated with breaking news from Millenium Pharmaceuticals Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Product revenue for the first six months of 2023 increased to $22.7 million, compared to $3.9 million for the same period in 2022Investors, including Teva Pharmaceuticals, subscribed to Alvotech’s...
Product revenue for the first six months of 2023 increased to $22.7 million, compared to $3.9 million for the same period in 2022Investors, including Teva Pharmaceuticals, subscribed to Alvotech’s subordinated convertible bonds for an aggregate amount of $140 million in July 2023Expanded its existing commercialization partnerships with Teva Pharmaceuticals for the US and with Advanz Pharma for EuropeSettlement reached with Johnson & Johnson securing a US license entry date for AVT04, Alvotech’s
(Bloomberg) -- Alnylam Pharmaceuticals Inc. Chief Executive Officer John Maraganore, a legend in the biotech industry, will step down from his post at year-end to be succeeded by Chief Operating Officer Yvonne Greenstreet. The shares fell the most in three years.